降低PFKFB3的调节加剧了 ангиотензинII诱导的 podocyte 脱离
Xiaoxiao Huang1, Zhaowei Chen1,2, Zilv Luo1
1Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China.
Renal failure
|July 10, 2023
概括
果糖-2,6-双酸酶3 (PFKFB3) 通过维持 podocyte 粘附,保护脏免受损伤. 减少PFKFB3表达会使慢性病 (CKD) 恶化,突出显示PFKFB3是细胞损伤的治疗标.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 足细胞损失是慢性病 (CKD) 的关键驱动因素.
- 导致细胞损失的确切机制尚不完全理解.
- 果糖-2,6-双酸酶3 (PFKFB3) 影响细胞粘附,生存和新陈代谢.
研究的目的:
- 为了研究PFKFB3在血管素II (Ang II) 诱导的损伤中的作用.
- 探索PFKFB3对细胞粘附和功能的影响.
主要方法:
- 在小鼠中输注 ангиотензин II,以诱导脏损伤.
- 在体外研究使用细胞培养来评估 podocyte 行为.
- 药理上抑制和激活PFKFB3,分别使用3PO和meclizine.
- 分析PFKFB3表达,塔林1酸化和整合素β1亚单元 (ITGB1) 活性.
主要成果:
- 格II输液导致细胞脱离,降低功能,降低PFKFB3的表达.
- 抑制PFKFB3加剧了Ang II诱导的细胞损失,而PFKFB3激活则减轻了损失.
- 抑制PFKFB3 knockdown抑制了talin1的酸化和ITGB1的活性,从而导致受体细胞损失.
结论:
- ангиотензин II 通过降低 PFKFB3 表达来降低 podocyte 粘附.
- PFKFB3在维持 podocyte 完整性方面发挥着保护作用.
- 在CKD中,PFKFB3代表了一种潜在的治疗点,可以减轻细胞损伤.
相关概念视频
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
786
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
786
01:25Antihypertensive Drugs: Direct Renin Inhibitors
697
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
697
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
696
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
696
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
465
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
465
01:29Acute Kidney Injury II: Pathophysiology
34
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
34
01:33Hormonal Regulation
33.4K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.4K